Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2Gastrointestinal 2Genitourinary 1Breast 1

Conditions

Prostatic Neoplasms 5Pain, Postoperative 2Urinary Bladder Neoplasms 1Neoplasms 1Kidney Neoplasms 1Carcinoma, Renal Cell 1Agnosia 1

Interventions

Transcutaneous Electric Nerve Stimulation 2Lidocaine 2Ketorolac 2Acupuncture Therapy 2Surveys and Questionnaires 1Ropivacaine 1Oxycodone 1Music Therapy 1Morphine 1Ketamine 1Epinephrine 1Diazepam 1Clonidine 1Anesthesia, Local 1Analgesia, Epidural 1Acupressure 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Agnosia × Ropivacaine × Genitourinary × Clear all
NCT07092566 2026-01-20

R.E.C.K vs Exparel in Robotic Nephrectomy

Wake Forest University Health Sciences

Phase 3 Recruiting
170 enrolled
Genitourinary

Agnosia, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡